Entera Bio(ENTX)
Israel - Jerusalem
Biotechnology1 H-1B visas (FY2023)Focus: Oral Biologics
Entera Bio is a life sciences company focused on Oral Biologics.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Products & Portfolio (5)
45 discontinued products not shown
GEMCITABINE
gemcitabine
Pre-Launch
INJECTION · INJECTABLE
IBANDRONATE SODIUM
ibandronate sodium
Pre-Launch
INJECTION · INJECTABLE
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
Post-LOE
INJECTION · INJECTABLE
2008
30
LEVALBUTEROL HYDROCHLORIDE
levalbuterol hydrochloride
Post-LOE
INHALATION · SOLUTION
2014
30
PANTOPRAZOLE SODIUM
pantoprazole sodium
Pre-Launch
INJECTION · INJECTABLE
Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 54 approved products
Top TAs: Oncology, Respiratory, Nephrology
H-1B (2023): 1 approval
SEC Filings: 2 available
Portfolio Health
Pre-Launch7 (13%)
LOE Approaching2 (4%)
Post-LOE45 (83%)
54 total products
Therapeutic Area Focus
Oncology
4 marketed
Respiratory
3 marketed
Nephrology
2 marketed
Neurology
2 marketed
Immunology
2 marketed
Infectious Diseases
1 marketed
Endocrinology
1 marketed
Gastroenterology
1 marketed
Marketed
Pipeline
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub